Formulation, In Vitro Optimization and In Vivo Evaluation of Sustained Release Transdermal Patches of Venlafaxine Hydrochloride

Faculty Pharmacy Year: 2017
Type of Publication: ZU Hosted Pages: 1664-74
Authors:
Abdelwahab Ali Hassan Ali Khidr
Journal: Latin American Journal of Pharmacy Latin American Journal of Pharmacy Volume: 8
Keywords : Formulation, , Vitro Optimization , , Vivo Evaluation , Sustained Release    
Abstract:
Recently, transdermal drug delivery systems (TDDS) attracted a great interest in pharmaceutical research owing to their marked patient compliance and low side effect. Venlafaxine hydrochloride (VFH), a novel antidepressant drug, showed ex
    
     
 
       

Author Related Publications

  • Abdelwahab Ali Hassan Ali Khidr, "FORMULATION AND EVALUATION OF VENLAFAXINE HYDROCHLORIDE TABLET", PHARMA SCIENCE MONITOR, 2016 More

Department Related Publications

  • Amr Selim Ahmed Ali Abu Lila, "Activation of TLR9 by incorporated pDNA within PEG-coated lipoplex enhances anti-PEG IgM production", nature, 2014 More
  • Fakhreldeen Soliman Ghazy Shehata, "Treatment of pulmonary arterial hypertension by vardenafil-solid dispersion lozenges as a potential alternative drug delivery system", Elsevier, 2020 More
  • Amr Selim Ahmed Ali Abu Lila, "Treatment of pulmonary arterial hypertension by vardenafil-solid dispersion lozenges as a potential alternative drug delivery system", Elsevier, 2020 More
  • Azza Ali Hassan Solyman, "Treatment of pulmonary arterial hypertension by vardenafil-solid dispersion lozenges as a potential alternative drug delivery system", Elsevier, 2020 More
  • Eman Gomaa Ahmed alsayed, "Treatment of pulmonary arterial hypertension by vardenafil-solid dispersion lozenges as a potential alternative drug delivery system", Elsevier, 2020 More
Tweet